CEMRIAV
Live / Registered — Registered (as of 26 Mar 2024)
What this means for you
Registered since 26 Mar 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97797523
- Registration number
- 7336285
- Mark type
- Stylized text
- Filed
- 16 Feb 2023
- Published for opposition
- 09 Jan 2024
- Registered
- 26 Mar 2024
- Attorney of record
- Bassam N. Ibrahim
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of cancer, oncological diseases, leukemia, musculoskeletal disorders, muscular dystrophy, pseudoxanthoma, dermatological disorders, allergy, cardiovascular diseases, kidney diseases, fibrodysplasia ossificans progressiva, systemic lupus erythematosus, Netherton syndrome; vaccines
Owner
- DAIICHI SANKYO COMPANY, LIMITED, Chuo-ku, Tokyo, JP
- DAIICHI SANKYO COMPANY, LIMITED, Chuo-ku, Tokyo, JP
- DAIICHI SANKYO COMPANY, LIMITED, Chuo-ku, Tokyo, JP
Prosecution history
- 26 Mar 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 26 Mar 2024 — REGISTERED-PRINCIPAL REGISTER
- 09 Jan 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 09 Jan 2024 — PUBLISHED FOR OPPOSITION
- 20 Dec 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 30 Nov 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 30 Nov 2023 — EXAMINER'S AMENDMENT ENTERED
- 30 Nov 2023 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 30 Nov 2023 — EXAMINERS AMENDMENT E-MAILED
- 30 Nov 2023 — EXAMINERS AMENDMENT -WRITTEN
- 24 Nov 2023 — PREVIOUS ALLOWANCE COUNT WITHDRAWN
- 10 Oct 2023 — WITHDRAWN FROM PUB - OG REVIEW QUERY
- 28 Sept 2023 — ELECTRONIC RECORD REVIEW COMPLETE
- 22 Sept 2023 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
- 20 Sept 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER